{'fraction_non_alphanumeric': 0.02781136638452237, 'fraction_numerical': 0.020556227327690448, 'mean_word_length': 4.447368421052632, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Development Of A 14 Fr. Size Hemopump

One of the latest advancements in miniature blood pump technology is under development by Nimbus, Inc. This device is a smaller version of the Hemopump currently undergoing clinical trials in the United States. Compared to the original 21 Fr. size (7 mm diameter) Hemopump the smaller device is 14 Fr. (4.6 mm diameter) in size, but has roughly the same blood flow capacity. Motivation to create the 14 Fr. pump is for treatment of smaller patients or ones who have sclerotic or small torturous vessels that prevent placement of the 21 Fr. device. Also, the 14 Fr. can be introduced percutaneously, and this has implications for more widespread usage by non-surgeons. This paper outlines the major physical characteristics of the 14 Fr. pump and summarizes its current development status.